Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation

Thorax

Volumn 49, Issue 5, 1994, Pages 479-484

  Jaeschke, R ^a   Guyatt, G H ^a   Cook, D ^a   Ramsdale, H ^a   Haddon, R ^a   Newhouse, M ^a   Willan, A ^a   Harper, S ^a   Morris, J ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b Astra Pharma Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PULMONARY VENTILATION; QUALITY OF LIFE; TERBUTALINE; TREMOR;

EID: 0028341807     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.49.5.479     Document Type: Article

References (0)